Pictet Asset Management
WST icon

Pictet Asset Management’s West Pharmaceutical WST Stock Holding History

Pictet Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.1M Sell
44,190
-107,807
-71% -$26.8M 0.01% 633
2025
Q4 		$41.8M Sell
151,997
-38,116
-20% -$10.4M 0.04% 357
2025
Q3 		$49.9M Sell
190,113
-20,389
-10% -$4.96M 0.05% 327
2025
Q2 		$46.1M Buy
210,502
+76,151
+57% +$16.3M 0.05% 328
2025
Q1 		$30.1M Buy
134,351
+16,880
+14% +$4.65M 0.03% 397
2024
Q4 		$38.5M Sell
117,471
-17,574
-13% -$5.53M 0.04% 351
2024
Q3 		$40.5M Sell
135,045
-2,854
-2% -$874K 0.04% 335
2024
Q2 		$45.4M Buy
137,899
+35,985
+35% +$12.7M 0.05% 300
2024
Q1 		$40.3M Buy
101,914
+62,452
+158% +$23.1M 0.04% 350
2023
Q4 		$13.9M Sell
39,462
-755
-2% -$267K 0.02% 564
2023
Q3 		$15.1M Buy
+40,217
New +$15.6M 0.02% 533

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pictet Asset Management's WST Position: Q1 2026 in Review

Pictet Asset Management reduced its West Pharmaceutical (WST) stake by 71% in Q1 2026, selling an estimated $26.8M and leaving 44,190 shares worth $11.1M. The position accounts for 0.01% of the portfolio, ranked #633.

Pictet Asset Management first reported a position in WST in Q3 2023 and has held it in 11 quarters since. The position peaked at $49.9M in Q3 2025. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Pictet Asset Management held 44,190 shares of West Pharmaceutical worth $11.1M as of Q1 2026.
  • Pictet Asset Management sold 107,807 West Pharmaceutical shares in Q1 2026, an estimated $26.8M.
  • West Pharmaceutical made up 0.01% of Pictet Asset Management's portfolio in Q1 2026, its #633 holding.
  • Pictet Asset Management first reported a position in West Pharmaceutical in Q3 2023 and has held it in 11 quarters since.
  • Pictet Asset Management's West Pharmaceutical position peaked at $49.9M in Q3 2025.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.